Free Trial

Regencell Bioscience (RGC) Institutional Ownership

Regencell Bioscience logo
$28.58 +1.67 (+6.21%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$28.03 -0.55 (-1.92%)
As of 05/15/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Regencell Bioscience (NASDAQ:RGC)

Current
Institutional Ownership
Percentage
0.13%
Number of
Institutional Buyers
(last 12 months)
9
Total
Institutional Inflows
(last 12 months)
$12.34M
Number of
Institutional Sellers
(last 12 months)
4
Total
Institutional Outflows
(last 12 months)
$2.55M
Get RGC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Regencell Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

RGC Institutional Buying and Selling by Quarter

Regencell Bioscience Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/26/2026 Seven Fleet Capital Management LP4,400$92K0.1%N/A0.001%
2/18/2026 Vident Advisory LLC29,934$629K0.0%+65.7%0.006%
2/18/2026 XTX Topco Ltd15,081$317K0.0%-61.1%0.003%
2/16/2026 Squarepoint Ops LLC26,011$546K0.0%-49.2%0.005%
2/13/2026 Hudson Bay Capital Management LP13,107$275K0.0%N/A0.003%
2/9/2026 Geode Capital Management LLC413,082$8.68M0.0%-1.6%0.084%
11/17/2025 XTX Topco Ltd38,735$598K0.0%N/A0.008%
11/14/2025 Squarepoint Ops LLC51,249$792K0.0%-48.7%0.010%
11/13/2025 BNP Paribas Financial Markets4,682$72K0.0%-89.6%0.001%
8/27/2025 Squarepoint Ops LLC99,843$1.70M0.0%N/A0.000%
8/15/2025 BNP Paribas Financial Markets45,050$768K0.0%N/A0.000%
8/14/2025 Squarepoint Ops LLC99,843$1.70M0.0%N/A0.000%
8/8/2025 Geode Capital Management LLC391,066$6.66M0.0%+5,637.5%0.000%
8/1/2025 Y Intercept Hong Kong Ltd13,042$222K0.0%N/A0.003%
7/7/2025 Greenfield Savings Bank11,000$187K0.1%N/A0.000%


RGC Institutional Ownership - Frequently Asked Questions

During the previous two years, 9 institutional investors and hedge funds held shares of Regencell Bioscience. The most heavily invested institutionals were Geode Capital Management LLC ($8.68M), Vident Advisory LLC ($629K), Squarepoint Ops LLC ($546K), XTX Topco Ltd ($317K), Hudson Bay Capital Management LP ($275K), Y Intercept Hong Kong Ltd ($222K), and Greenfield Savings Bank ($187K).Learn more on Regencell Bioscience's institutional investors.

0.13% of Regencell Bioscience's stock is owned by institutional investors. Learn more on RGC's institutional investor holdings.

Of the 9 institutional investors that purchased Regencell Bioscience's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($384.25K), Squarepoint Ops LLC ($199.69K), BNP Paribas Financial Markets ($45.05K), XTX Topco Ltd ($38.74K), Hudson Bay Capital Management LP ($13.11K), Y Intercept Hong Kong Ltd ($13.04K), and Vident Advisory LLC ($11.87K).

Institutional investors have bought a total of 721,136 shares in the last 24 months. This purchase volume represents approximately $12.34M in transactions.

The following institutional investors have sold Regencell Bioscience stock in the last 24 months: Squarepoint Ops LLC ($73.83K), BNP Paribas Financial Markets ($40.37K), XTX Topco Ltd ($23.65K), and Geode Capital Management LLC ($6.89K).

Institutional investors have sold a total of 144,742 shares in the last 24 months. This volume of shares sold represents approximately $2.55M in transactions.



This page (NASDAQ:RGC) was last updated on 5/17/2026 by MarketBeat.com Staff.
From Our Partners